Mölnlycke Health Care AB: CEO, Zlatko Rihter, announces resignation, Guillaume Joucla appointed interim CEO
Tue, Mar 24, 2026 Today, it was announced that Zlatko Rihter, CEO of Mölnlycke Health Care, has informed the Board of Directors of his decision to resign. Following his decision, Guillaume Joucla, Chief Financial Officer, has been appointed interim CEO of Mölnlycke Health Care. Mölnlycke’s Board has initiated the recruitment process for a permanent CEO.
“Zlatko has been instrumental in navigating Mölnlycke through an ever‑changing world while delivering above‑market growth. The company has made significant progress, with a relentless focus on customer centricity and geographic expansion,” says Mölnlycke’s Chair of the Board, Karl-Henrik Sundström.
“It has been a privilege to lead Mölnlycke for more than five years, a period of fantastic development and growth. The company is well positioned to continue its growth journey. I am proud of what we have achieved, and I want to sincerely thank all my colleagues for their hard work and strong commitment. I would also like to thank the Board for its support during my tenure,” says Zlatko Rihter.
“We are pleased to have Guillaume Joucla serve as interim CEO and lead the company forward, building on its key strengths. Guillaume has an excellent track record and extensive experience, having served almost 20 years with the company,” says Karl-Henrik Sundström.
Latest news
-
Mölnlycke Health Care breaks ground on $135 million expansion of Wound Care manufacturing facility in Brunswick, Maine
Brunswick, Maine, USA and Gothenburg, Sweden. 23 September 2025. Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, today celebrates the groundbreaking of a major expansion to its wound care manufacturing capacity in Brunswick, Maine. This milestone marks the beginning of a $135 million investment aimed at significantly increasing Mölnlycke’s manufacturing capacity in the United States.
-
High burnout among operating room staff poses significant risk to patient safety—new review reveals
Gothenburg, Sweden. 17 September 2025. A new narrative review published in the current issue of Journal of Patient Safety, titled ’Putting Patients at Risk: The Effect of Health Care Provider Burnout on Patient Care in the Operating Room’ reveals alarmingly high levels of burnout among healthcare workers in operating rooms (ORs) and warns of the serious implications for staff well-being, care quality and ultimately patient safety.
-
Mölnlycke awarded second consecutive EcoVadis Platinum medal for sustainability performance
Gothenburg, Sweden. 21 August 2025. Mölnlycke®, a world-leading MedTech company, has once again been recognised as a global sustainability leader, earning the prestigious EcoVadis Platinum medal for the second year in a row.
-
New study highlights the importance of double gloving with indicator systems
A new peer-reviewed study published in the Journal of Hospital Infection underscores the critical role of double gloving and indicator systems in reducing the risk of undetected glove breaches during surgery.
-
July, the peak of the grill season, and grill-related burn injuries!
July means grilling season for many, but let's not forget the importance of safety. This month records the highest number of grill-related fires and reported burn injuries. At Mölnlycke, your well-being is our priority, so we asked experts for their tips on essential first aid advice and burn prevention strategies for the summer. Have a safe summer!
-
Mölnlycke advocates a holistic approach to healthcare sustainability
New white paper calls for integration of environmental, human and economic metrics in sustainability assessments of medical technologies.
-
Filippa Stenberg joins Mölnlycke Board of Directors
-
Mölnlycke Health Care inaugurates new global headquarters at GoCo Health Innovation City
Gothenburg, Sweden. 21 May 2025 – Mölnlycke Health Care, a global leader in MedTech, has officially opened its new global headquarters at GoCo Health Innovation City in Gothenburg, Sweden—a major milestone in its journey to drive sustainable healthcare innovation.
-
Mölnlycke Health Care’s long-term target to reach net zero emissions validated by Science Based Targets initiative
Gothenburg, Sweden. 13 May, 2025. Mölnlycke’s long-term net zero greenhouse gas (GHG) emission reduction targets have been validated by the Science Based Targets initiative (SBTi), following prior validation of the company’s near-term GHG emission reduction targets.